Castle Creek Arbitrage’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding CANO.WS
ZA
ICM
CAC
AWG
DKCM
JAIC
GL
Castle Creek Arbitrage's CANO.WS Position: Q4 2022 in Review
Castle Creek Arbitrage sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2022, closing a stake of 89,845 shares — an estimated $235K sold.
Castle Creek Arbitrage first reported a position in CANO.WS in Q2 2021 and held it in 6 quarters. The position peaked at $372K in Q3 2021. 27 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2022.
- Castle Creek Arbitrage reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2022 after selling out during the quarter.
- Castle Creek Arbitrage sold 89,845 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2022, an estimated $235K.
- Castle Creek Arbitrage first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2021 and held it in 6 quarters.
- Castle Creek Arbitrage's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $372K in Q3 2021.
- 27 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2022.
Based on Castle Creek Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.